You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞太藥業(002370.SZ):收到枸櫞酸莫沙必利顆粒藥品註冊受理通知書
格隆匯 06-22 20:35

格隆匯 6 月 22日丨亞太藥業(002370.SZ)公佈,公司於近日收到國家藥品監督管理局下發的藥品註冊受理通知書,產品名稱為枸櫞酸莫沙必利顆粒。

枸櫞酸莫沙必利顆粒為消化道促動力劑,主要用於緩解慢性胃炎伴有的燒心、早飽、上腹脹、上腹痛、噁心、嘔吐等消化系統症狀;口服腸道洗淨劑的硫酸鋇灌腸X射線造影檢查前處理補充。枸櫞酸莫沙必利是選擇性5-羥色胺(5-HT4)受體激動劑,可以刺激存在於消化道內在神經叢的5-HT4受容體,通過增大乙酰膽鹼遊離,顯示出了上消化道以及下消化道的運動促進作用。

根據國家藥品註冊相關的法律法規要求,上述藥品在獲國家藥品監督管理局註冊申請受理後將轉入國家藥品監督管理局藥品審評中心進行審評審批,完成時間、審批結果均具有不確定性,上述產品獲得註冊受理對公司近期業績不會產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account